MS INTERNATIONAL PLC — Director's Dealing 2022

Feb 3, 2022

National Storage Mechanism | Additional information

RNS Number : 6661A

SourceBio International PLC

03 February 2022

3 February 2022

SourceBio International plc

("SourceBio", the "Company" or the "Group")

Director/PDMR Shareholding

SourceBio International plc ("the Company") has been notified that on 2 February 2022, Harwood Capital LLP transferred 1,901,973 ordinary shares of 0.15 pence each in the Company ("Ordinary Shares") to Limited Partners of Harwood Private Equity IV L.P. ("HPE4") in order to satisfy distributions, in the normal course of business.

Christopher Mills, Non-Executive Director of the Company is Chief Executive of Harwood Capital LLP.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Harwood Capital LLP as investment manager

2

Reason for the notification

a)

Position/status

Christopher Mills is a non-executive director of the issuer and Chief Executive of the investment manager

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

SourceBio International Plc

b)

LEI

213800KY4C9WU7WBW518

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of  £0.0015 each

Identification code

GB00BKSB1674

b)

Nature of the transaction

Transfer of shares

c)

Price(s) and volume(s)

Price(s)	Volume(s)
Nil	1,901,973

d)

Aggregated information

Volume

Price

N/A - single transaction

e)

Date of the transaction

2 February 2022

f)

Place of the transaction

Off market

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BKSB1674

Issuer Name

SOURCEBIO INTERNATIONAL PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Harwood Capital Management (Gibraltar) Limited

City of registered office (if applicable)

Gibraltar

Country of registered office (if applicable)

Gibraltar

Name	City of registered office	Country of registered office
Harwood Capital LLP	London	United Kingdom

4. Details of the shareholder

Name	City of registered office	Country of registered office
Oryx International Growth Fund Limited	St Peter Port	Guernsey
North Atlantic Smaller Companies Investment Trust plc	London	United Kingdom
Harwood Capital LLP	London	United Kingdom

5. Date on which the threshold was crossed or reached

02-Feb-2022

6. Date on which Issuer notified

03-Feb-2022

7. Total positions of person(s) subject to the notification obligation

	% of voting rights attached to shares (total of 8.A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)	Total of both in % (8.A + 8.B)	Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached	23.540000	0.000000	23.540000	17464284
Position of previous notification (if applicable)	26.810000	0.000000	26.810000	19891969

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)	Number of direct voting rights (DTR5.1)	Number of indirect voting rights (DTR5.2.1)	% of direct voting rights (DTR5.1)	% of indirect voting rights (DTR5.2.1)
GB00BKSB1674	2500000		3.370000
GB00BKSB1674	13250000		17.860000
GB00BKSB1674	1714284		2.310000
Sub Total 8.A	17464284		23.540000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument	Expiration date	Exercise/conversion period	Number of voting rights that may be acquired if the instrument is exercised/converted	% of voting rights
Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument	Expiration date	Exercise/conversion period	Physical or cash settlement	Number of voting rights	% of voting rights
Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person	Name of controlled undertaking	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
Christopher Harwood Bernard Mills	Oryx International Growth Fund Limited	3.370000
Christopher Harwood Bernard Mills	North Atlantic Smaller Companies Investment Trust plc	17.860000
Christopher Harwood Bernard Mills	Harwood Capital LLP	2.310000

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

12. Date of Completion

03-Feb-2022

13. Place Of Completion

Off market

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFIDFAIVIIF